Carotenoids and modulation of cancer: Molecular targets

Current Pharmacogenomics

Volumn 2, Issue 1, 2004, Pages 35-45

  Palozza, Paola ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYMETHYLURACIL; 5,6 DIHYDRO 5,6 DIHYDROXYTHYMIDINE; 8 HYDROXYDEOXYGUANOSINE; AFLATOXIN B1; ALPHA TOCOPHEROL; ASCORBIC ACID; ASTAXANTHIN; BENZO[A]PYRENE; BETA CAROTENE; BIOLOGICAL MARKER; CANTHAXANTHIN; CARCINOGEN; CAROTENOID; CONNEXIN 43; CYCLIN DEPENDENT KINASE; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2A; CYTOCHROME P450 3A; DNA; GLUTATHIONE TRANSFERASE; LYCOPENE; ORNITHINE DECARBOXYLASE; PROTEIN P53; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); RETINOL; THYMINE; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR SUPPRESSOR PROTEIN;

ANGIOGENESIS; APOPTOSIS; BLADDER CANCER; BREAST CANCER; CANCER CELL CULTURE; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CHROMOSOME ABERRATION; CIGARETTE SMOKING; COLON CANCER; DETOXIFICATION; DIET SUPPLEMENTATION; DIETARY INTAKE; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; DRUG MECHANISM; DRUG TARGETING; EPIDEMIOLOGICAL DATA; FOOD COMPOSITION; FRUIT; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENOTOXICITY; HORMONE ACTION; HOST; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSURVEILLANCE; INHIBITION KINETICS; LIVER CANCER; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR MECHANICS; MOUSE; MOUTH CANCER; MUTAGENESIS; NONHUMAN; OXIDATION; OXIDATION REDUCTION STATE; PATHOPHYSIOLOGY; PROSTATE CANCER; PROTEIN FUNCTION; RAT; REVIEW; SALIVARY GLAND CANCER; SISTER CHROMATID EXCHANGE; SKIN CANCER; TREATMENT FAILURE; VEGETABLE;

EID: 3042803407     PISSN: 15701603     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570160043476169     Document Type: Review

References (132)

1. Alabaster, O.; Tang, Z.; Frost, A.; Shivapurkar, N. (1995) Effect of beta-carotene and wheat bran fiber on colonic aberrant crypt and tumor formation in rats exposed to azoxymethane and high dietary fat. Carcinogenesis 16, 127-132.
2. Alam, B.S.; Alam, S.Q. (1987) The effect of different levels of dietary beta-carotene on DMBA-induced salivary gland tumors. Nutr. Cancer 9, 93-101.
3. Amir, H.; Karas, M.; Giat, J.; Danilenko, M.; Levy, R.; Yermiahu, T.; Levy, J.; Sharoni, Y. (1999) Lycopene and 1,25-dihydroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells. Nutr. Cancer 33, 105-112.
4. Astorg, P.; Gradelet, S.; Bergés, R.; Suschetet, M. (1996) No evidence for an inhibitory effect of beta-carotene or of canthaxanthin on the initiation of liver preneoplastic foci by diethylnitrosamine in the rat. Nutr. Cancer 25, 27-34.
5. Bendich, A. (1994) Recent advances in clinical research involving carotenoids. Pure Appl. Chem. 66, 1025-1032.
6. Ben-Dor, A.; Nahum, A.; Danilenko, M.; Giat, Y.; Stahl, W.; Martin, H.D.; Emmerich, T.; Noy, N.; Levy, J.; Sharoni, Y. (2001) Effects of acyclo-retinoic acid and lycopene on activation of the retinoic acid receptor and proliferation of mammary cancer cells. Arch. Biochem. Biophys. 391, 295-302.
7. Bishayee, A.; Sarkar, A.; Chatterjee, M. (2000) Further evidence for chemopreventive potential of beta-carotene against experimental carcinogenesis: diethylnitrosamine-initiated and phenobarbital-promoted hepatocarcinogenesis is prevented more effectively by beta-carotene than by retinoic acid Nutr. Cancer 37, 89-98.
8. Black, H.S.; Okotie-Eboh, G.; Gerguis, J. (2000) Diet potentiates the UV-carcinogenic response to beta-carotene. Nutr. Cancer 37, 173-178.
9. Blot, W.J.; Li, J.; Taylor, P.R.; Guo, W.; Dawsey, S.; Wang, G.O.; Yang, C.S.; Zheng, S.F.; Gail, M.; Li, G:Y.; Yu, Y.; Liu, B.-Q.; Tangrea, J.; Sun, Y.-H.; Liu, F.; Fraumeni, J.F. Jr.; Zhang, Y.-H; Li, B. (1993) Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J. Natl. Cancer Inst. 85, 1483-1492.
10. Boyle, J.O.; Langenfeld, J.; Lonardo, F.; Sekula, D.; Reczek, P.; Rusch, V.; Dawson, M.I.; Dmitrovsky, E. (1999) Cyclin D1 proteolysis: a retinoid chemoprevention signal in normal, immortalized, and transformed human bronchial epithelial cells. J. Natl. Cancer Inst. 91, 373-379.
11. Buckley, M.F.; Sweeney, K.J.; Hamilton, J.A.; Sini, R.L.; Manning, D.L.; Nicholson, R.I.; deFazio, A.; Watts, C.K.; Musgrove, E.A.; Sutherland, R.L. (1993) Expression and amplification of cyclin genes in human breast cancer. Oncogene 8, 2127-2133.
12. Cahill, R.J.; O'Sullivan, K.R.O.; Mathias, P.M. (1993) Effects of vitamin antioxidant supplementation on cell kinetics of patients with adenomatous polyps. Gut 34, 963-967.
13. Carnero, A. (2002) Targeting the cell cycle for cancer therapy. Br. J. Cancer 87, 129-133.
14. Cohen, L.A.; Zhao, Z.; Pittman, B.; Khachik, F. (1999) Effect of dietary lycopene on N-methylnitrosourea-induced mammary tumorigenesis. Nutr. Cancer 34, 153-159.
15. Collins, A.R. (2001) Carotenoids and genomic stability. Mutat. Res. 475, 21-28.
16. Collins, A.R.; Olmedilla, B.; Southon, S.; Granado, F., Duthie, S. J. (1998) Serum carotenoids and oxidative DNA damage in human lymphocytes. Carcinogenesis 19, 2159-2162.
17. Covacci, V.; Torsello, A.; Palozza, P.; Sgambato, A.; Romano, G.; Boninsegna, A.; Cittadini, A.; Wolf, F.I. (2001) DNA oxidative damage during differentiation of HL-60 human promyelocytic leukemia cells. Chem. Res. Toxicol. 14, 1492-1497.
18. Cozzi, R.; Ricordy, R.; Aglitti, T.; Gatta, V.; Perticone, P.; and De Salvia, R. (1997) Ascorbic acid and β-carotene as modulators of oxidative damage. Carcinogenesis 18, 223-228.
19. Cozzi, R.; Ricordy, R.; Aglitti, T.; Gatta, V.; Perticone, P. and De Salvia, R. (1997) Ascorbic acid and β-carotene as modulators of oxidative damage. Carcinogenesis 18, 223-228.
20. Dameron, K.M.; Volpert, O.V.; Tainsky, M.A.; Bouck, N. (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265, 1582-1584.
21. Daudu, P.A.; Kelley, D.S.; Taylor, P.C.; Burri, B.; Wu, M.M. (1994) Effect of a low β-carotene diet on the immune functions of adult women. Am. J. Clin. Nutr. 60, 969-972.
22. Duthie, S.; Ma, A.; Ross, M.A.; and Collins, A.R. (1996) Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res. 56, 1291-1295.
23. Escribano, J.; Alonso, G.; Coca-Prados, M.; Fernandez, J. (1996) Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro. Cancer Lett. 100, 23-30.
24. Fischer, D.E. (1994) Apoptosis in cancer therapy: crossing the threshold. Cell 78, 539-542.
25. Frommel, T.O.; Mobarhan, S.; Doria, M.; Halline, A.G.; Luk, G.D.; Bowen, P.E.; Candel, A.; Liao, Y. (1995) Effect of beta-carotene supplementation on indices of colonic cell proliferation. J. Natl. Cancer Inst. 87, 1781-1787.
26. Gerster, H. (1993) Anticarcinogenic effect of common carotenoids. Int. J. Vitam. Nutr. Res. 63, 93-121.
27. Gradelet, S.; Le Bon, A.-M.; Bergés, R.; Suschetet, M.; Astorg, P. (1998) Dietary carotenoids inhibit aflatoxin B1-induced liver preneoplastic foci and DNA damage in the rat: role of the modulation of aflatoxin B1 metabolism. Carcinogenesis 19, 403-411.
28. Greenberg, E.R.; Baron, J.A.; Tosteson, T.D.; Freeman, DHJr; Beck, GJ; Bond, JH; Colacchio, T.A.; Coller, J.A.; Frankl, H.D.; Haile, R.W. (1994). A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N. Engl. J. Med. 331, 141-147.
29. Guttenplan, J.B.; Chen, M.; Kosinska, W.; Thompson, S.; Zhao, Z.; Cohen, L.A. (2001) Effects of a lycopene-rich diet on spontaneous and benzo[a]pyrene-induced mutagenesis in prostate, colon and lungs of the lacZ mouse. Cancer Lett. 164, 1-6.
30. Hanahan, D.; Weinberg; R.A. (2000) The hallmarks of cancer. Cell 100, 57-70.
31. Hazuka, M.B.; Edwards-Prasad, J.; Newman, F.; Kinzie, J.J.; Prasad, K.N. (1990) β-Carotene induces morphological differentiation and decreases adanylate cyclase activity in melanoma cells. J. Am. Coll. Nutr. 9, 143-149.
32. Hennekens, C.H.; Buring, J.E.; Manson, J.E.; Stampfer, M.; Rosner, B.; Cook, N.R.; Belanger, C.; LaMotte, F.; Gaziano, J.M.; Ridker, P.M.; Willett, W.; Peto, R. (1996) Lack of effect of long-term supplementation with β-carotene on the incidence of malignant neoplasm and cardiovascular disease. N. Engl. J. Med. 334, 1145-1149.
33. Imaida, K.; Tamano, S.; Kato, K.; Ikeda, Y.; Asamoto, M.; Takahashi, S.; Nir, Z.; Murakoshi, M.; Nishino, H.; Shirai, T. (2001) Lack of chemopreventive effects of lycopene and curcumin on experimental rat prostate carcinogenesis. Carcinogenesis 22, 466-472.
34. Jacobson, M.D.; Weil, M.; Raff, M.C. (1997) Programmed cell death in animal development. Cell 88, 347-354.
35. Jyonouchi, H.; Sun, S.; Mikzokami, M.; Gross, M.D. (1996) Effects of various carotenoids on cloned, effector-stage T-helper cell activity. Nutr. Cancer 26, 313-324.
36. Jyonouchi, H.; Sun, S.; Tomita, Y.; Gross, M.D. (1995) The effect of carotenoids on in vitro immunoglobulin production by human peripheral blood mononuclear cells: Astaxanthin, a carotenoid without vitamin A activity. Augments antibody responses in cultures including t-helper cell clones and suboptimal doses of antigen. J. Nutr. 124, 2483-2492.
37. Kane, D.J.; Sarfian, T.A.; Anton, R.; Hahn, H.; Gralla, E.B.; Valentine, J.S.; Ord, T.; Bredesen, D.E. (1993) Bcl-2 inhibition of neural death decreased generation of reactive oxygen species. Science 262, 1274-1277.
38. Karas, M.; Amir, H.; Fishman, D.; Danilenko, M.; Segal, S.; Nahum, A.; Koifmann, A.; Giat, Y.; Levy, J.; Sharoni, Y. (2000) Lycopene interferes with cell cycle progression and insulin-like growth factor I signalling in mammary cancer cells. Nutr. Cancer 36, 101-111.
39. Katsumura, N.; Okuno, M.; Onogi, N.; Moriwaki, H.; Muto, Y.; Kojima, S. (1996) Suppression of mouse skin papilloma by canthaxanthin and β-carotene in vivo: possibility of the regression of tumorigenesis by carotenoids without conversion to retinoic acid. Nutr. Cancer 26, 203-208.
40. Kessova, I.G.; Leo, M..; Liebler, C.S. (2001) Effect of β-carotene on hepatic cytochrome P450 in ethanol-fed rats. Alcohol Clin. Exp. Res. 25, 1368-1372.
41. Kikendall, J.W.; Mobarhan, S.; Nelson, R.; Burgess, M. (1991) Oral beta-carotene does not reduce the recurrence of colorectal adenomas. Am. J. Gastroenterol. 36, 1361.
42. Kim, J.M.; Araki, S.; Kim, D.J.; Park, C.B.; Takasuka, N.; Baba-Torijama, H.; Ota, T.; Nir, Z.; Khachik, F.; Shimidzu, N.; Tanaka, Y.; Osawa, T.; Uraji, T.; Murakoshi, M.; Nishino, H.; Tsuda, H. (1998) Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2-dimethylhydrazine initation. Carcinogenesis 19, 81-85.
43. Konopacka, M., Widel, M., Rzeszowska-Wolny, J. (1998) Modifying effect of vitamins C, E and beta-carotene against gamma-ray-induced DNA damage in mouse cells Mutat. Res. 417, 85-94.
44. Krinsky, N.I. (1991) Effects of carotenoids in cellular and animal systems. Am. J. Clin. Nutr. 53, 238S-246S.
45. Krinsky, N.I. (1993) Action of carotenoids in biological systems. Annu. Rev. Nutr. 13, 561-587.
46. La Rosa, F.A.; Pierce, J.W.; Sonenshein, G.E. (1994) Differential regulation of the c-myc oncogene promoter by the NF-kB Rel family of transcription factors. Mol. Cell. Biol. 14, 1039-1044.
47. Lee, B.M.; Lee, S.K.;Kim, H.S. (1998) Inhibition of oxidative DNA damage, 8-OH-dG, and carbonyl contents in smokers treated with antioxidants (Vitamin E, Vitamin C, β-Carotene and red ginseng) Cancer Lett. 132, 219-227.
48. Liebovich, S.J.; Polverini, P.J.; Shepard, H.M.; Wiseman, D.M.; Shively, V. et al. (1987) Macrophage induced angiogenesis is mediated by tumor necrosis factor alpha. Nature 329, 630-637.
49. Liu, C.; Wang, X.D.; Bronson, R.T.; Smith, D.E.; Krinsky, N.I.; Russell, R.M. (2000) Effects of physiological versus pharmacological β-carotene supplementation on cell proliferation and histopathological changes in the lungs of cigarette smoke-exposed ferrets. Carcinogenesis 21, 2245-2253.
50. Lotan, J.; Sacks, L. (1993) Regulation by Bcl-2, c-myc and p53 and susceptibility to induction of apoptosis by heat shock cancer chemotherapy compounds in differentiation-competent and defective myeloid leukemic cells. Cell Growth Diff. 4, 41-47.
51. Lowe, G.M.; Booth, I.A.; Bilton, R.F.; Young, A.J. (1999) Lycopene and beta-carotene protect against oxidative damage in HT29 cells at low concentrations but rapidly lose this capacity at higher doses. Free Radic. Res. 30, 141-151.
52. Lowe, S.W.; Lin, A.W. (2000) Apoptosis in cancer. Carcinogenesis 21, 485-495.
53. Lowe, S.W.; Ruley, H.E.; Jacks, T.; Housman, D.E. (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer drugs. Cell 74, 957-967.
54. McLennan, R.; Macrae, F.; Bain, C.; Battistutta, D.; Chapuis, P.; Gratten, H.; Lambert, J.; Newland, R.C; Ngu, M.; Russell, A.; Ward, M.; Wahlquist, M.L. (1995) Randomized trial of intake of fat, fiber, and beta-carotene to prevent colorectal adenomas. The Australian Polyp Prevention Project. J. Natl. Cancer Inst. 87, 1760-1766.
55. Mathews-Roth, M.M. (1982) Antitumor activity of β-carotene, canthaxanthin and phytoene. Oncology 39, 33-37.
56. Mayne, S.T. (1996) Beta-carotene, carotenoids and disease prevention in humans. FASEB J. 10, 690-701.
57. Mullaart, E.; Lohman, P.H.M.; Berends, F.; Vijg, J. (1990) DNA damage metabolism and aging. Mutat Res. 237, 189-210.
58. Muller, K.; Carpenter, K.L.; Challis, I.R.; Skepper, J.N.; Arends, M.J. (2002) Carotenoids induce apoptosis in the T-lymphoblast cell lines Jurkat E-6.1. Free Rad. Res. 36, 791-802.
59. Murakami, C.; Takemura, M.; Sugiyama, Y.; Kamisuki, S.; Asahara, H.; Kawasaki, M.; Ishidoh, T.; Linn, S.; Yoshida, S.; Sugawara, F.; Yoshida, H.; Sakaguchi, K.; Mizushina, Y. (2002) Vitamin A-related compounds, all-trans retinal and retinoic acids, selectively inhibit activities of mammalian replicative DNA polymerases. Biochim. Biophys. Acta 1574, 85-92.
60. Murakoshi, M.; Nishino, H.; Satomi, Y.; Takayasu, J.; Hasegawa, T.; Tokuda, H.; Iwashima, A.; Okuzumi, I.; Okabe, H.; Kitano, H. (1992). Potent preventive action of alpha-carotene against carcinogenesis: spontaneous liver carcinogenesis and promoting stage of lung and skin carcinogenesis in mice are suppressed more effectively by alpha-crotene than beta-carotene. Cancer Res. 52, 3583-6587.
61. Murakoshi, M.; Takayasu, J.; Kimura, O.; Kohmura, E.; Nishino, H.; Iwashima, A.; Okuzumi, J.; Sakai, T.; Sugimoto, T.; Imanishi, J.; Iwasaki, R. (1989) Inhibitory effects of α-Carotene on proliferation of the human neuroblastoma cell line GOTO. J. Natl. Cancer Inst. 81, 1649-1652.
62. Muto, Y.; Fujii, J.; Shidoji, Y.; Moriwaki, H.; Kawaguchi, T.; Noda, T. (1995) Growth retardation in human cervical-derived cell lines by β-carotene through down regulation of epidermal growth factor receptor. Am. J. Clin. Nutr. 62, 1535S-1540S.
63. Nahum, A.; Hirsch, K.; Danilenko, M.; Watts, C.K.; Prall, O.W.; Levy, J.; Sharoni, Y. (2001) Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27Kip1 in the cyclin E-cdk2 complexes. Oncogene 20, 3428-3436.
64. Nara, E.; Hayashi, H.; Kotake, M.; Miyashita, K.; Nagao, A. (2001) Acyclic carotenoids and their oxidation mixtures inhibit the growth of HL-60 human promyelocytic leukemia cells. Nutr. Cancer 39, 273-283.
65. Nierenberg, D:W:; Stukel, T.A.; Baron, J.A.; Dain, B.S., Greenberg, E.R. (1991) Determinants of increase in plasma concentrations of β-carotene after chronic oral supplementation. Am. J. Clin. Nutr. 53, 1443-1449.
66. Nikawa, T.; Schulz, W.A.; van den Brink, C.E.; Hanusch, M.; van der Saag, P.; Stahl, W.; Sies, H. (1994) Efficacy of all-trans-β-carotene, canthaxanthin, and all-trans-, 9-cis, and 4-oxoretinoic acids in inducing differentiation of an F9 embryonal carcinoma RAR beta-lacZ reporter cell line. Arch. Biochem. Biophys. 316, 665-672.
67. Nurse, P. (1997) Checkpoint pathways come of age. Cell 91, 865-867.
68. Obermuller-Jevic, U.C.; Francz, P.I.; Frank, J.; Flaccus, A.; Biesalski, H.K. (1999) Enhancement of the UVA-induction of haem oxygenase-1 expression by β-carotene in human skin fibroblasts. FEBS Lett. 460, 212-216.
69. Okajima, E.; Ozono, S.; Endo, T.; Majima, T.; Tsutsumi, M.; Fukuda, T.; Akai, H.; Denda, A.; Hirao, Y.; Okajima, E.; Nishino, H.; Nir, Z.; Konishi, Y. (1997) Chemopreventive efficacy of piroxicam administered alone or in combination with lycopene and beta-carotene on the development of rat urinary bladder carcinoma after N-butyl-N-(4-hydroxybutyl)nitrosamine treatment. Jpn. J. Cancer Res. 88, 543-552.
70. Okuzumi, J.; Nishino, H.; Murakoshi, M.; Iwashima, A.; Tanaka, Y.; Yamane, T.; Fujita, Y.; Takahashi, T. (1990) Inhibitory effects of fucoxanthin, a natural carotenoid, on N-myc expression and cell cycle progression in human malignant tumor cells. Cancer Lett. 55, 75-81.
71. Omenn, G.S.; Goodman, G.E.; Thornquist, M.D.; Balmes, J.; Cullen, M.R.; Glass, A.; Keogh, J.P.; Meyskens, F.L.; Valanis, B.; Williams, J.H.; Barnhart, S.; and Hammar, S. (1996) Effects of a combination of β-carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 334, 1150-1155.
72. Owuor, E.D:; Kong, A.-N. T. (2002) Antioxidants and oxidants regulated signal transduction pathways. Biochem. Pharmacol. 64, 765-770.
73. Palozza, P. (1998a) Prooxidant actions of carotenoids in biological systems Nutr. Rev. 56, 357-265.
74. Palozza, P., Serini, S.; Torsello, A.; Di Nicuolo, F.; Piccioni, E.; Ubaldi, V.; Pioli, C.; Wolf, F.I., Calviello, G. (2003a) β-Carotene regulates NF-kB DNA-binding activity by a redox mechanism in human leukemia and colon adenocarcinoma cells. J. Nutr. 133: 381-388.
75. Palozza, P.; Calviello, G.; Serini, S.; Maggiano, N.; Lanza, P.; Ranelletti, F.O.; Bartoli, G.M. (2001) β-Carotene at high concentrations induces apopptosis by enhancing oxy-radicals production in human adenocarcinoma cells. Free Rad. Biol. Med. 30, 1000-1007.
76. Palozza, P.; Calviello, G.; Serini, S.; Moscato, P.; Luberto, C.; Bartoli, G.M. (1997) Antitumor effect of an oral administration of canthaxanthin in BALB/c mice bearing thymoma cells. Nutr. Cancer 28, 199-205.
77. Palozza, P.; Maggiano, N.; Calviello, G.; Lanza, P.; Piccioni, E.; Ranelletti, F.O.; Bartoli, G.M. (1998b) Canthaxanthin induces apoptosis in human cancer cell lines. Carcinogenesis 19, 373-376.
78. Palozza, P.; Serini, S.; Di Nicuolo, F.; Calviello, G. (2001) Mitogenic and apoptotic signaling by carotenoids: involvement of a redox mechanism. IUBMB Life 52, 1-5.
79. Palozza, P.; Serini, S.; Maggiano, N.; Angelini, M.; Boninsegna, A.; Di Nicuolo, F.; Ranelletti, F.O. and Calviello, G. (2002a) Induction of cell cycle arrest and apoptosis in human colon adenocarcinoma cell lines by β-carotene through down-regulation of cyclin A and Bcl-2 family proteins. Carcinogenesis 23, 11-18.
80. Palozza, P.; Serini, S.; Torsello, A.; Boninsegna, A.; Covacci, V.; Maggiano, M.; Ranelletti, F:O.; Wolf, F.I. and Calviello, G. (2002b) Regulation of cell cycle progression and apoptosis by β -carotene in undifferentiated and differentiated HL-60 leukemia cells: possible involvement of a redox mechanism. Int. J. Cancer 97, 593-600.
81. Palozza, P.; Serini, S.; Torsello, A.; Di Nicuolo, F.; Maggiano, M.; Ranelletti, F:O.; Wolf, F.I.; Calviello, G. (2003b) Mechanism of activation of caspase cascade during β-carotene-induced apoptosis in human tumor cells. Nutr. Cancer, in press.
82. Paolini, M.; Cantelli, A.; Pozzetti, L.; Spetlova, D.; Perocco, P.; Valgimigli, L; Pedulli, G.F. and Cantelli-Forti, G. (2001) Induction of cytochrome P450 enzymes and over-generation of oxygen radicals in β-carotene supplemented rats. Carcinogenesis 22, 1483-1495.
83. Paolini, M.; Cantelli-Forti, G.; Perocco, P.; Peduli, G:F.; Abdel-Rahman, S.Z. and Legator, M.S. (1999) Co-carcinogenic effect of β-carotene. Nature 398: 760-761.
84. Perocco, P.; Paolini, M.; Mazzullo, M.; Biagi, G.L.; Cantelli-Forti, G. (1999) β-carotene as enhancer of cell-transforming activity of powerful carcinogens and cigarette-smoke condensate on Balb/c 3T3 cells in vitro Mutat. Res. 440, 83-90.
85. Peto, R.; Doll, R.; Buckley, J. D.; Sporn, M. B. (1981) Can dietary beta-carotene materially reduce human cancer rates Nature (Lond.) 290, 201-208.
86. Phillips, R.W.; Kikendall, J.W. Luk, G.D.; Willis, S.M.; Murphy, J.R.; Maydonovitch, C.; Bowen, P.E.; Stacewicz-Sapuntzakis, M; Wong, R.K. (1993) Beta-carotene inhibits rectal mucosal ornithine decarboxylase activity in colon cancer patients. Cancer Res. 53, 3723-3725.
87. Ponnamperuma, R.M.; Shimizu, Y.; Kirchhof, S.M.; De Luca, L.M. (2000) Beta-carotene fails to act as a tumor promoter, induces RAR expression and prevents carcinoma formation in a two-stage model of skin carcinogenesis in male Sencar mice. Nutr. Cancer 37, 82-88.
88. Pool-Zobel, B.L:; Bub, A:; Muller, H.; Wollowski, I. and Rechkemme,r G. (1997) Consumption of vegetables reduces genetic damage in humans: first results of a human intervention trial with carotenoid-rich foods. Carcinogenesis 18, 1847-1850.
89. Prakash, P.; Jackson, C.L.; Gerber, L.E. (1999) Subcellular accumulation of β-carotene and retinoids in growth-inhibited NCI-H69 small cell lung cancer cells. Nutr. Cancer 34, 76-82.
90. Prakash, P.; Manfredi, T.G.; Jackson, C.L.; Gerber, L.E. (2002) β-Carotene alters the morphology of NCI-H69 small cell lung cancer cells J. Nutr. 132, 121-124.
91. Prince, M.R.; Frisoli, J.K. (1993) Beta-carotene accumulation in serum and skin. Am. J. Clin. Nutr. 57, 175-181.
92. Rao, A.V.; Agarwal, S. (1998) Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer. Nutr. Cancer 31, 199-203.
93. Rao, A.V.; Agarwal, S. (1998) Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in prevention of cancer. Nutr. Cancer 31, 199-203.
94. Ratnasinghe, D.; Tangrea, J.A.; Andersen, M.R.; Barrett, M.J.; Virtamo, J; Taylor, P.R.; Albanes, D. (2000) Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res. 60, 6381-6383.
95. Rauscher, R.; Edenharder, R.; Platt, K.L. (1998) In vitro antimutagenic and in vivo anticlastogenic effects of carotenoids and solvent extracts from fruits and vegetables rich in carotenoids. Mutat. Res. 413, 12-142.
96. Rock, C.L.; Kusluki, R.A.; Galvez, M.M.; Ethier, S.P. (1995) Carotenoids induce morphological changes in human mammary epithelial cell cultures Nutr. Cancer 23, 319-333.
97. Salgo, M.G.; Cueto, R.; Winston, G.W.; Pryor, W.A. (1999) Beta carotene and its oxidation products have different effects on microsome mediated binding of benzo[a]pyrene to DNA. Free Rad. Biol. Med. 26, 162-173.
98. Salvadori, D.M.F.; Ribeiro, R.R.; Natarajan, A.T. (1994) Effects of β-carotene on clastogenic effects of mytomycin C, methyl methanesulphonate and bleomycin in Chinese Hamster ovary cells. Mutagenesis 9, 53-57.
99. Schwartz, J.; Shklar, G. (1992) The selective cytotoxic effect of carotenoids and α-tocopherol on human cancer cell lines in vitro. J. Oral. Maxillofac. Surg. 50, 367-373.
100. Schwartz, J.L. (1993) In vitro biological methods for determination of carotenoid activity. Methods Enzymol. 214, 226-256.
101. Schwartz, J.L. (1996) The dual roles of nutrients as antioxidant and prooxidants: their effects on tumor cell growth. J. Nutr. 126, 1221S.
102. Schwartz, J.L.; Antoniades, D.Z.; Zhao, S.(1993). Molecular and biochemical reprogramming of oncogenesis through the activity of antioxidants and prooxidants. Ann. NY Acad. Sci. 1228, 262-279.
103. Schwartz, J.L.; Flynn, E.; Shklar, G. (1990) The effects of carotenoids on the antitumor immune response in vitro and in vivo with hamster and mouse immune effectors. Ann. NY Acad. Sci. 587, 92-109.
104. Schwartz, J.L.; Shklar, G.(1997) Retinoid and carotenoid angiogenesis: a possible explanation for enhanced oral carcinogenesis. Nutr. Cancer 27, 192-199.
105. Sharoni, Y.; Danilenko, M.; Walfisch, S.; Amir, H.; Naum, A.; Ben-Dor, A.; Hirsch, K.; Khanin, M.; Steiner, M.; Agemy, L.; Zango, G.; Levy, J. (2002) Role of gene regulation in the anticancer activity of carotenoids. Pure Appl. Chem. 74, 1469-1477.
106. Sharoni, Y.; Giron, E.; Rise, M.; Levy, J. (1997) Effects of lycopene-enriched tomato oleoresin on 7,12-dimethyl-benz[a]anthracene-induced rat mammary tumors. Cancer Detect. Prev. 21, 118-123.
107. Shklar, G.; and Schwartz, J.L. (1994) A commom pathway for the destruction of cancer cells: experimental evidence and clinical implications, Int. J. Oncol.,4, 215-224.
108. Shklar, G.; Schwartz, J.L. (1988) Tumor necrosis factor in experimental cancer: regression with alpha-tocopherol, beta-carotene and algae extract. Eur. J. Cancer Clin. Oncol. 24, 839-850.
109. Stivala, L.A.; Savio, M.; Quarta, S.; Scotti, C.; Cazzalini, O.; Rossi, L.; Scovassi, I.A.; Pizzala, R.; Melli, R.; Bianchi, L.; Vannini, V.; Prosperi, E. (2000) The antiproliferative effects of β-carotene requires p21waf1/cip1 in normal human fibroblasts. Eur. J. Biochem. 267, 2290-2296.
110. Suda, D.; Schwartz, J.; Shklar, G. (1986) Inhibition of experimental oral carcinogenesis by topical β-carotene. Carcinogenesis 7, 711-715.
111. Sumantran, V.N.; Zhang, R.; Lee, D.S.; Wicha, M.S. (2000) Differential regulation of apoptosis in normal versus transformed mammary epithelium by lutein and retinoic acid. Cancer Epidemiol. Biomark. Prev. 9, 257-263.
112. Tanaka, T.; Makita, H.; Ohnishi, M.; Mori, H.; Satoh, K.; Hara, A. (1995) Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin. Cancer Res .55, 4059-4064.
113. Tanaka, T.; Morishita, Y.; Suzui, M.; Kojima, T.; Okumura, A.; Mori, H. (1994) Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin. Carcinogenesis 15, 15-19.
114. Tarantilis, P.A.; Morjani, H.; Polissiou, M.; Manfait, M. (1994) Inhibition of growth and induction of differentiation of promyelocytic leukemia (HL-60) by carotenoids from Crocus sativus L. Anticancer Res. 14, 1913-1918.
115. The Alpha-tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers. (1994) N. Engl. J. Med.330, 1029-1035.
116. Thornberry, N.A.; Lazebnik, Y. (1998) Caspases: enemies within. Science 281, 1312-1316.
117. Tibaduiza, E.C.; Fleet, J.C.; Russell, R.M.; Krinsky, N.I. (2002) Excentric cleavage products of β-carotene inhibit estrogen receptor positive and negative breast tumor cell growth in vitro and inhibit activator protein-1-mediated transcriptional activation. J. Nutr. 132, 1368-1375.
118. Tokino, T.; Nakamura, Y. (2000) The role of p53-target genes in human cancer. Critical Rev. in Oncol./Hematol.33, 1-6.
119. Toma, S.; Albanese, E.; Palumbo, R.; Nicolo, G.; Morerio, C.; Mangiante, P.E.; Bonatti, S.; Cancedda, R.; Santi, L. (1991) In vitro effects of beta-carotene on human keratinocytes from precancerous lesions and squamous carcinoma. Anticancer drugs 2, 581-589.
120. Tomita, Y. (1989) Studies on the role of nutrition and diet in prevention of cancer. Bull. Phys. Fitness Res. Inst. 72, 116-120.
121. Wang, X.D.; Liu, C.; Bronson, R.T.; Smith, D.E.; Krinsky, N.I.; Russell, R.M. (1999) Retinoid signalling and Activator Protein-1 expression in ferrets given β-carotene supplements and exposed to tobacco smoke. J. Natl. Cancer Inst. 91, 60-66.
122. Weidner, N.; Caroll, P.R.; Flax, J.; Blumenfeld, W., Folkaman, J. (1993) Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol. 143, 401-409.
123. Williams, A.W.; Boileau, T.W.-M.; Zhou, J.R.; Clinton, S.K.; Erdman, J.W. (2000) Beta-carotene modulates human prostate cancer cell growth and may undergo intracellular metabolism to retinol J. Nutr. 130, 728-732.
124. Witschi, H.; Espiritu, I.; Suffia, M.; Pinkerton, K.E. (2002) Expression of cyclin D1/2 in the lungs of strain A/J mice fed chemopreventive agents. Carcinogenesis 23, 289-294.
125. Wolterbeek, A.P.M.; Roggeband, R.; van Moorsel, C.J.A.; Baan, R.A.; Koeman, J.H.; Feron, V.J.; Rutten, A.A.J.J.L. (1995) Vitamin A and beta-carotene influence the level of benzo[a]pyrene-induced DNA adducts and DNA-repair activities in hamster tracheal epithelium in organ culture. Cancer Lett. 91, 205-214.
126. Woods, J.A.; Bilton, R.F.; Young, A.J. (1999) Beta-carotene enhances hydrogen peroxide-induced DNA damage in human hepatocellular HepG2 cells. FEBS Lett. 449, 255-258.
127. Woodson, K.; Ratnasinghe, D.; Bhat, N.K.; Stewat, C.; Tangrea, J.A.; Hartman, T.J.; Stolzenberg-Solomon, R.; Virtamo, J; Taylor, P.R.; Albanes, D. (1999) Prevalence of disease-related DNA polymorphisms among participants in a large cancer prevention trial. Eur. J. Cancer Prev. 8, 441-447.
128. Yeh, S.L.; Hu M.L. (2001) Induction of oxidative DNA damage in human foreskin fibroblast Hs68 cells by oxidized β-carotene and lycopene. Free Rad. Res. 35, 203-213.
129. Zhang, L.-X.; Cooney, R.V.; Bertram, J. S. (1991) Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis 12, 2109-2114.
130. Zhang, L.-X.; Cooney, R.V.; Bertram, J. S. (1992) Carotenoids up-regulate connexion 43 gene expression independent of their pro-vitamin A or antioxidant properties. Cancer Res. 52, 5707-5712.
131. Zhang, P., Omaye, S.T. (2001) DNA strand breakage and oxygen tension: effects of β-carotene, α-tocopherol, and ascorbic acid. Food Chem. Toxicol. 39, 239-246.
132. Zhao, Z.; Khachik, F.; Richie, J.P.Jr.; Cohen, L.A. (1998) Lycopene uptake and tissue disposition in male and female rats. Proc. Soc. Exp. Bio. Med. 218, 109-114.